Vinceti A, Iannuzzi R, Boyle I, Trastulla L, Campbell C, Vazquez F
Genome Biol. 2024; 25(1):192.
PMID: 39030569
PMC: 11264729.
DOI: 10.1186/s13059-024-03336-1.
Dietzen M, Zhai H, Lucas O, Pich O, Barrington C, Lu W
Nat Commun. 2024; 15(1):6039.
PMID: 39019871
PMC: 11255325.
DOI: 10.1038/s41467-024-50107-4.
Weber S, Chawla H, Ehrig L, Hickey L, Frisch M, Snowdon R
Front Plant Sci. 2023; 14:1221750.
PMID: 37936929
PMC: 10627008.
DOI: 10.3389/fpls.2023.1221750.
Vuaroqueaux V, Musch A, Kobelt D, Risch T, Herrmann P, Burock S
Cancers (Basel). 2022; 14(7).
PMID: 35406521
PMC: 8997143.
DOI: 10.3390/cancers14071749.
Chen S, Wu Y, Wang S, Wu J, Wu X, Zheng Z
J Ovarian Res. 2022; 15(1):39.
PMID: 35361267
PMC: 8973612.
DOI: 10.1186/s13048-022-00969-3.
Fully exploiting SNP arrays: a systematic review on the tools to extract underlying genomic structure.
Balague-Dobon L, Caceres A, Gonzalez J
Brief Bioinform. 2022; 23(2).
PMID: 35211719
PMC: 8921734.
DOI: 10.1093/bib/bbac043.
Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
Shao M, Jiang L, Meng Z, Xu J
Molecules. 2022; 27(4).
PMID: 35209193
PMC: 8878172.
DOI: 10.3390/molecules27041404.
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity....
Bao Y, Gabrielpillai J, Dietrich J, Zarbl R, Strieth S, Schrock F
Clin Epigenetics. 2021; 13(1):228.
PMID: 34933671
PMC: 8693503.
DOI: 10.1186/s13148-021-01212-4.
Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers.
Vuaroqueaux V, Hendriks H, Al-Hasani H, Peille A, Das S, Fiebig H
NPJ Precis Oncol. 2021; 5(1):96.
PMID: 34711913
PMC: 8553758.
DOI: 10.1038/s41698-021-00235-7.
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations.
Fedrizzi T, Ciani Y, Lorenzin F, Cantore T, Gasperini P, Demichelis F
Comput Struct Biotechnol J. 2021; 19:4394-4403.
PMID: 34429855
PMC: 8369001.
DOI: 10.1016/j.csbj.2021.08.001.
Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S, Hu P, Lakowski T
BMC Cancer. 2021; 21(1):648.
PMID: 34059012
PMC: 8166022.
DOI: 10.1186/s12885-021-08359-6.
Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor.
Jaiswal A, Gautam P, Pietila E, Timonen S, Nordstrom N, Akimov Y
Mol Syst Biol. 2021; 17(3):e9526.
PMID: 33750001
PMC: 7983037.
DOI: 10.15252/msb.20209526.
Impact of between-tissue differences on pan-cancer predictions of drug sensitivity.
Lloyd J, Soellner M, Merajver S, Li J
PLoS Comput Biol. 2021; 17(2):e1008720.
PMID: 33630864
PMC: 7906305.
DOI: 10.1371/journal.pcbi.1008720.
In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
Lee J, Lee K, Kim J
Int J Mol Sci. 2021; 22(3).
PMID: 33499282
PMC: 7865701.
DOI: 10.3390/ijms22031097.
Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens.
Ayestaran I, Galhoz A, Spiegel E, Sidders B, Dry J, Dondelinger F
Patterns (N Y). 2020; 1(5):100065.
PMID: 33205120
PMC: 7660407.
DOI: 10.1016/j.patter.2020.100065.
Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL.
Zaccaria S, Raphael B
Nat Biotechnol. 2020; 39(2):207-214.
PMID: 32879467
PMC: 9876616.
DOI: 10.1038/s41587-020-0661-6.
Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.
Peille A, Vuaroqueaux V, Wong S, Ting J, Klingner K, Zeitouni B
Commun Biol. 2020; 3(1):367.
PMID: 32647357
PMC: 7347869.
DOI: 10.1038/s42003-020-1077-z.
MetaCNV - a consensus approach to infer accurate copy numbers from low coverage data.
Friedrich S, Barbulescu R, Helleday T, Sonnhammer E
BMC Med Genomics. 2020; 13(1):76.
PMID: 32487140
PMC: 7268502.
DOI: 10.1186/s12920-020-00731-y.
Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
Khalil A, Khyriem C, Chattopadhyay A, Sanyal A
BMC Bioinformatics. 2020; 21(1):147.
PMID: 32299346
PMC: 7160937.
DOI: 10.1186/s12859-020-3480-3.
Copy number variation is highly correlated with differential gene expression: a pan-cancer study.
Shao X, Lv N, Liao J, Long J, Xue R, Ai N
BMC Med Genet. 2019; 20(1):175.
PMID: 31706287
PMC: 6842483.
DOI: 10.1186/s12881-019-0909-5.